(Q40761947)

English

Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Echizen H

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Ohta Y

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Shirataki H

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Tsukamoto K

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Umeda N

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Oda T

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Ishizaki T

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 June 1990

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

562-567

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Effects of influenza virus vaccine on hepatic drug metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Depression of theophylline elimination following BCG vaccination

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Effects of interferons in neoplastic diseases of man.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Inhibition of antipyrine metabolism by interferon

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Inhibition of theophylline metabolism by interferon

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Effects of alpha-interferon on theophylline pharmacokinetics and metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Effeets of etiocholanolone-indueed fever on plasma antipyrine half-lives and metabolie elearanee

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

The effect of fever on antipyrine metabolism in children

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Antipyrine clearance in pneumonia

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Antipyrine clearance and metabolism in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Introduction to sample size determination and power analysis for clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Sample size nomograms for interpreting negative clinical studies

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

The antipyrine test in clinical pharmacology: Conceptions and misconceptions

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Induction and depression of cytochrome P-450-dependent mixed-function oxidase by a cloned consensus alpha-interferon (IFN-alpha CON1) in the hamster

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03621.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1990.TB03621.X

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40761947&oldid=1906754521"